Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

BIGTK PEER ANALYSIS

Big Medya Teknoloji Anonim Sirketi — metric-by-metric comparison with peers and the industry median

BIGTKBig Medya Teknoloji Anonim Sirketi

🇹🇷 Turkey · IS · Communication Services · Publishing

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Publishing

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
BIGTKIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
BIGTK—INF+15.3%PSON+18.7%SCHL+119.1%WLY+26.1%
Year-to-Date (YTD)
BIGTK-16.5%INF+4.5%PSON+20.1%SCHL+57.6%WLY+73.1%
1-Year
Split-adjusted
BIGTK—HURGZ+3.3%IHGZT-4.3%
Year-to-Date (YTD)
BIGTK-16.5%HURGZ+22.8%IHGZT-14.1%

Key Metric Comparison

P/E

Lower is better
BIGTK108.30INF—PSON24.06SCHL19.01WLY12.48Median 21.53

ROE

Higher is better
BIGTK10.8%INF0.2%PSON8.7%SCHL6.9%WLY27.7%Median 6.9%

Net Margin

Higher is better
BIGTK8.8%INF0.3%PSON9.4%SCHL3.9%WLY13.2%Median 8.4%

Revenue Growth

Higher is better
BIGTK25.2%INF20.1%PSON0.7%SCHL1.4%WLY-0.1%Median 10.4%

P/E

Lower is better
BIGTK108.30HURGZ—IHGZT4.88Median 21.53

ROE

Higher is better
BIGTK10.8%HURGZ-46.8%IHGZT5.8%Median 6.9%

Net Margin

Higher is better
BIGTK8.8%HURGZ-91.3%IHGZT8.4%Median 8.4%

Revenue Growth

Higher is better
BIGTK25.2%HURGZ-8.4%IHGZT13.3%Median 10.4%

All Metrics

Valuation
MetricBIGTKINFPSONSCHLWLYInd. Median
P/E108.30—24.0619.0112.48●21.53
P/B5.932.112.211.37●3.262.11
EV/EBITDA41.5412.168.176.24●13.3612.76
P/S9.562.952.250.74●1.652.25
Financial Health
MetricBIGTKINFPSONSCHLWLYInd. Median
Current Ratio1.530.442.00●1.180.541.53
Debt/Equity5.9%●61.6%40.6%32.6%90.6%19.3%
NetDebt/EBITDA0.03●2.541.020.822.680.58
Profitability
MetricBIGTKINFPSONSCHLWLYInd. Median
Net Margin8.8%0.3%9.4%3.9%13.2%●8.4%
ROE10.8%0.2%8.7%6.9%27.7%●6.9%
ROA6.9%0.1%5.0%3.4%8.4%●4.6%
EBITDA Margin23.0%30.6%31.5%●13.6%15.4%15.4%
Growth + Dividend
MetricBIGTKINFPSONSCHLWLYInd. Median
Rev. Growth25.2%●20.1%0.7%1.4%-0.1%10.4%
NI Growth210.7%-96.5%-22.8%237.1%●163.3%30.7%
Div. Yield0.0%2.4%2.0%1.7%2.8%●1.1%
Payout0.0%2,437.3%47.8%33.5%33.6%31.0%
Valuation
MetricBIGTKHURGZIHGZTInd. Median
P/E108.30—4.88●21.53
P/B5.931.720.24●2.11
EV/EBITDA41.54●—166.7112.76
P/S9.563.140.41●2.25
Financial Health
MetricBIGTKHURGZIHGZTInd. Median
Current Ratio1.531.186.58●1.53
Debt/Equity5.9%4.4%2.3%●19.3%
NetDebt/EBITDA0.03-0.45-21.79●0.58
Profitability
MetricBIGTKHURGZIHGZTInd. Median
Net Margin8.8%●-91.3%8.4%8.4%
ROE10.8%●-46.8%5.8%6.9%
ROA6.9%●-22.3%4.6%4.6%
EBITDA Margin23.0%●-17.1%0.2%15.4%
Growth + Dividend
MetricBIGTKHURGZIHGZTInd. Median
Rev. Growth25.2%●-8.4%13.3%10.4%
NI Growth210.7%●—30.7%30.7%
Div. Yield0.0%●0.0%●0.0%●1.1%
Payout0.0%0.0%0.0%31.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BIGTK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.